Boston Partners - AKEBIA THERAPEUTICS INC ownership

AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 173 filers reported holding AKEBIA THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.47 and the average weighting 0.1%.

Quarter-by-quarter ownership
Boston Partners ownership history of AKEBIA THERAPEUTICS INC
ValueSharesWeighting
Q1 2020$531,000
-82.5%
70,003
-85.4%
0.00%
-50.0%
Q4 2019$3,032,000
+156.5%
479,636
+59.0%
0.00%0.0%
Q3 2019$1,182,000
-0.8%
301,603
+22.5%
0.00%0.0%
Q2 2019$1,192,000
-48.6%
246,266
-13.0%
0.00%
-33.3%
Q1 2019$2,318,000
+50.0%
283,044
+1.3%
0.00%
+50.0%
Q4 2018$1,545,000279,3780.00%
Other shareholders
AKEBIA THERAPEUTICS INC shareholders Q1 2019
NameSharesValueWeighting ↓
Alerce Investment Management, L.P. 4,652,561$1,471,0001.42%
Orchard Capital Management, LLC 251,826$80,0000.03%
GSA CAPITAL PARTNERS LLP 486,568$154,0000.02%
Icon Wealth Advisors, LLC 400,132$1270.02%
ACADIAN ASSET MANAGEMENT LLC 7,483,053$2,365,0000.01%
JACOBS LEVY EQUITY MANAGEMENT, INC 2,042,816$646,0000.01%
WIPFLI FINANCIAL ADVISORS LLC, 200,000$63,0000.00%
WEALTH EFFECTS LLC 18,316$6,0000.00%
James J. Burns & Company, LLC 25,142$8,0000.00%
Bayesian Capital Management, LP 68,600$22,0000.00%
View complete list of AKEBIA THERAPEUTICS INC shareholders